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CHAPTER 1 INTRODUCTION 
 Pain is an unpleasant sensory and emotional experience in response to actual, perceived, 
or potential tissue damage (IASP, 1984). Pain is a warning signal that something is wrong and can 
have protective effects necessary for survival. The aversive quality of pain motivates an individual 
to withdraw from a dangerous situation and to seek help or medical attention in order to prevent 
further damage (Institute of Medicine, 2011). Perception of pain is unique to the individual and 
can be based on biological (sensory), psychological (emotional and cognitive), and social factors 
(Institute of Medicine, 2011). When pain becomes chronic, however, it is no longer protective and 
can negatively impact the well being of the suffering individual. It is estimated that 116 million 
people suffer from common chronic pain conditions including headaches and lower back pain. The 
economic cost of chronic pain is estimated to be between $560 and 635 billion dollars annually 
(Institute of Medicine, 2011). 
1.1 Stress & Pain 
 Stress produces bimodal effects on pain perception.  During exposure to a stressor 
responses to painful stimuli are inhibited, i.e. stress-induced analgesia (Butler & Finn, 2009); 
however, following exposure to a long-term stressor, increases in responsiveness to painful stimuli 
may develop; stress-induced hyperalgesia (Jennings, Okine, Roche, & Finn, 2014). Stressors 
activate a well-characterized subcortical circuit that detects threatening stimuli and produces innate 
defensive behaviors (Chapman, Tuckett, & Song, 2008; LeDoux, 2000).  Here, I evaluated how a 
key component of the subcortical defense circuit, the basolateral amygdala, contributes to 
production of both stress-induced analgesia and hyperalgesia. 
1.2 Defense Circuit 
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 A well-characterized subcortical defense circuit generates defensive behaviors, such as 
vocalizations, in response to a threat. This network developed as evolutionary pressures selected 
for a mechanism to encourage the avoidance of threats (Mobbs et al., 2010). For example, rodents 
that have been exposed to a natural predator will display freezing or flight behavior (Mobbs et al., 
2010). This circuit is composed primarily of hypothalamic nuclei, the periaqueductal gray (PAG), 
and medullary nuclei (Keay & Bandler, 2001).  
 Stress exposure results in a bimodal response of either active or passive coping strategies 
(Keay & Bandler, 2001). Active coping strategies can include motor activity, vigilance, 
hyperreactivity, and tachycardia, while passive strategies are associated with immobility, 
hypotension, and decreased vigilance (Keay & Bandler, 2001). An active or passive coping 
strategy is mediated by the PAG. The columnar organization within the PAG gives rise to these 
opposing responses (see Figure 1). Active coping strategies are activated by the lateral (lPAG) or 
dorsolateral (dlPAG) columns, while the ventrolateral (vlPAG) column is associated with passive 
strategies. A calm animal will respond as if there is a threat following activation of the lPAG or 
dlPAG (Keay & Bandler, 2001). Activation in the rostral region of these columns results in 
confrontational behavior and is associated with extracranial blood flow (Keay & Bandler, 2001). 
Activation in the caudal area leads to a flight or escape response and increased blood flow to 
skeletal muscles (Keay & Bandler, 2001). In contrast, activation of the vlPAG in calm prey 
animals, such as rats, results in immobility and bradycardia (Keay & Bandler, 2001). Activation 
of these different columns also results in differences in pain sensitivity. Non-opioid, short-term 
analgesia can be evoked by stimulation of the lPAG and dlPAG. Longer lasting, opioid mediated 
analgesia can be evoked following vlPAG stimulation (Keay & Bandler, 2001). 
3 
 
 
 
 In addition to different coping strategies, the different PAG columns have different afferent 
and efferent projections. Projections from lPAG and vlPAG terminate in the rostral ventral medulla 
(RVM) (Keay & Bandler, 2001). The dlPAG projects to the cuneiform nucleus, which then 
projects to the ventrolateral medulla (VLM) (Keay & Bandler, 2001). Therefore the PAG activates 
spinopetal inhibitory projections via the RVM and VLM (Basbaum & Fields, 1984; Keay & 
Bandler, 2001).  Spinal projections to the PAG terminate in the lateral and ventrolateral columns, 
with sensory information from the face and forelimbs projecting to the rostral regions and the 
lower half of the body projecting to the caudal region (Keay & Bandler, 2001). The dlPAG does 
not receive spinal input directly, and therefore is likely activated by non-physical stressors (Keay 
& Bandler, 2001).  
 The dlPAG and interconnected dorsomedial ventromedial hypothalamus (dmVMH) both 
show increased c-Fos activation following exposure to threatening stimuli (Canteras & Goto, 1999; 
Comoli, Ribeiro-Barbosa, & Canteras, 2003). Stimulation of these structures generates defensive 
behaviors and vocalizations even when not in the presence of a threat (Fernandez De Molina & 
Hunsperger, 1962).  For example, electrical or chemical stimulation of the dmVMH elicits 
vocalization after discharge (VAD)-like vocalizations in rats, and subthreshold chemical 
stimulation of dmVMH selectively lowered the threshold of tailshock elicited VADs and 
facilitated fear conditioning supported by tailshock (Borszcz, 2006).  In humans, stimulation of 
these sites leads to reports of fear and anxiety (Ervin, Mark, & Stevens, 1969; Iacono & Nashold, 
1982). The dmVMH sends glutamatergic projections to the dlPAG, which then coordinates activity 
within the brainstem to generate behavioral defensive and vocal responses (Jurgens, 2002; 
Schubert, Shaikh, & Siegel, 1996). In response, the dlPAG sends excitatory projections back to 
the dmVMH to create a positive feedback loop that sustains defensive responding during exposure 
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to an environmental threat (Bhatt, Gregg, & Siegel, 2003). Figure 2 shows a complete diagram of 
the brain structures and connections within the subcortical defense circuit.  
 The amygdala, which responds to threatening stimuli and attaches emotional significance 
to them (LeDoux, 2007), provides excitatory input to the subcortical defense circuit to generate 
defensive behaviors to a perceived threat (Shaikh, Schubert, & Siegel, 1994). As the prototypical 
threat is exposure to noxious stimuli, the amygdala receives nociceptive input to the central nucleus 
(CeA) through the spinoamygdaloid and the spinopontoamygdaloid pathways (Bernard, 1990; 
Jasmin, Burkey, Card, & Basbaum, 1997; Newman, Stevens, & Apkarian, 1996). The BLA also 
receives pain input through from the thalamus and cortex (Millan, 1999). 
 Together these structures generate the defensive behaviors and modulate pain responding. 
Fanselow and Lester (1988) suggest that the differences in behaviors, generated by the defense 
circuit, and subsequent effects on pain can be explained by the predator imminence theory. 
Defensive responding is determined by the prey's perception of the chance of consumption by a 
predator that generates the appropriate response. Imminence is determined by spatial and temporal 
distance of the threat as well as threat characteristics (Fanselow, 2016). Each animal has a 
repertoire of defensive behaviors that can be divided into pre-encounter, post-encounter, and circa-
strike behaviors. Pre-encounter behaviors include cautiousness to leave the nest, meal 
reorganization and hypervigilance (Fanselow and Lester, 1988). Post-encounter defensive 
behaviors include freezing in rats to avoid detection by the threat. Once contact with the threat or 
predator is imminent, circa-strike behaviors are used, including biting, jumping, and vocalizations 
in rats (Fanselow, 2016). Helmstetter and Fanselow (1993) have shown that as shock density 
increases, defensive behaviors increase within each stage until moving along this continuum to the 
next type of behavior. Therefore, predatory imminence determines the type of defensive behavior 
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that is generated which includes the subject’s response to noxious stimulation (see below). This is 
consistent with the active and passive coping strategies and columnar organization of the PAG 
presented by Keay and Bandler (2001). As threat level increases coping strategy will shift from a 
passive strategy, such as freezing, to a more active strategy of flight or fight if escape is not 
possible. These shifts in behavior can be explained by the defense circuit and PAG subcolumns 
(Keay and Bandler, 2001).  
1.3 Stress-Induced Analgesia 
 Fear and pain have been described as competing systems and, during a threatening situation 
fear is given priority while pain perception is suppressed (Bolles & Fanselow, 1982). This idea is 
also in line with the predator imminence theory. If contact with a predator is imminent, injury is 
likely to occur causing the animal to direct behavior toward the injured site detract from production 
of circa-strike behaviors. Situations activating circa-strike behaviors also activate endogenous 
analgesia systems (Fanselow and Lester, 1988). Endogenous analgesia is important for survival 
and prevents pain behaviors from disrupting the species-specific defense responding (Fanselow, 
1984). Thus aversive events generate defensive responding as well as analgesia, a phenomenon 
known as conditional analgesia or fear-conditioned analgesia. Exposure to a cat increased the 
shock threshold necessary to induce a tail-flick response and increased tail-flick latency to radiant 
heat (Lichtman and Fanselow, 1990). Further support for fear mediation of conditional analgesia 
is that midazolam and diazepam (GABA agonists) decrease freezing to a conditional stimulus 
previously paired with a footshock and increase recuperative behavior following shock (Fanselow 
& Helmstetter, 1988). Although, the analgesic effect during conditioning can be reversed with the 
opioid antagonists naloxone and naltrexone, it suggests that benzodiazepines (GABAA agonists) 
act at a site before the fear and analgesic systems diverge (Fanselow & Helmstetter, 1988).  
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 The amygdala is critical for Pavlovian fear conditioning and is the proposed site of 
integration of sensory and motor information underlying the expression of conditioned fear 
(Borszcz & Leaton, 2003). Diazepam microinjected into the basolateral amygdala (BLA) reduced 
the amount of burying (a measure of anxiety) as well as burying latency in the burying behavior 
test in addition to reducing pain symptoms associated with uric acid injection into the knee. A 
similar effect was seen when diazepam was microinjected into the dlPAG (Jimenez-Velazquez, 
Lopez-Munoz, & Fernandez-Guasti, 2010). The simultaneous anxiolytic and analgesic effect of 
diazepam suggest that these processes are related and can influence one another (Jimenez-
Velazquez et al., 2010). Lesions to the CeA elevated shock thresholds to elicit VADs in addition 
to preventing conditional vocalizations (Borszcz & Leaton, 2003). Further support for the role of 
the amygdala in conditional analgesia is the finding that muscimol, a GABAA agonist, prevented 
the expression of conditional fear as well as fear conditional analgesia (Rea, Roche, & Finn, 2011). 
Additionally, GABA levels were reduced in the BLA and dlPAG in animals undergoing fear 
conditioning (Rea, Lang, & Finn, 2009). 
 Amygdalar stimulation reduces tonic pain, as evidenced by decreased pain scores in the 
formalin test, based on time spent elevating, licking, or shaking the paw (Mena, Mathur, & Nayar, 
1995). Additionally, amygdalar activation decreases phasic pain as measured by increased tail flick 
latency to noxious heat (Mena et al., 1995). Electrical or chemical stimulation of the amygdala 
also alleviated affective pain, suggested by an increase in vocalization during discharge (VDS) 
and VAD thresholds to tail shock that was mediated via activation of the vlPAG (Mena et al., 
1995; Spuz & Borszcz, 2012, 2014). 
 Furthermore, morphine administered directly into the BLA increased VAD thresholds. 
These elevated responses were attenuated with a morphine antagonist (Nandigama & Borszcz, 
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2003). Additionally, the mu opioid agonist, DAMGO, when injected bilaterally into the BLA, 
increased tail flick latencies evoked by radiant heat (Helmstetter, Tershner, Poore, & Bellgowan, 
1998). This antinociceptive effect was mediated by both the RVM and vlPAG; lidocaine injected 
into these areas following morphine in the BLA attenuated the antinociceptive effect (Helmstetter 
et al., 1998). These findings suggest that spinal nociceptive reflexes can be modulated through a 
descending circuit that includes the amygdala as well as the PAG and RVM (Helmstetter et al., 
1998). 
1.4 Stress-Induced Hyperalgesia 
 While the analgesic effect of stress is well documented, the hyperalgesic effect associated 
with prolonged stress is less understood (Olango and Finn, 2014). Rhudy and Meagher (1999) 
suggest that this could be due to a failure of animal models and human studies to distinguish 
between fear and anxiety. Fear is a response to a present threat and mobilizes the organism to take 
action, whereas anxiety is a fear response to a perceived or potential threat that leads to increased 
environmental scanning and sensory receptivity (Rhudy & Meagher, 2000). This idea is also 
consistent with the predatory imminence theory. When a threat is not present, animals will 
maintain their preferred activities such as foraging and searching for a mate (Fanselow and Lester, 
1988). However, in anticipation of a threat, even when not present, these behaviors are readjusted 
to activate pre-encounter behaviors, which may reduce foraging, increase hypervigilance, and 
increase cautiousness to leave the nest (Fanselow and Lester, 1988). These behaviors increase 
reactivity to environmental stimuli, including noxious stimulation (Fanselow and Lester, 1988). 
   In order to observe the divergent effects on pain by fear and anxiety, Rhudy and Meager 
(2000) exposed human participants to a shock, a threat of shock, or a neutral condition and 
measured finger withdrawal latencies in a radiant heat test. Participants exposed to the shocks had 
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longer withdrawal latencies compared to the neutral condition (i.e., analgesia or antinociception), 
while participants who were told there may be shocks given had shorter withdrawal latencies 
compared to the neutral condition (i.e., hyperalagesia; Rhudy & Meagher, 2000). These results 
suggest the presence of two different phenomena, fear-induced analgesia and anxiety-induced 
hyperalgesia (Rhudy & Meagher, 2000).  
 Animal models have supported the phenomenon of anxiety-induced hyperalgesia as rats 
exposed to repeated social defeat stress exhibit anxiety-like behavior in the elevated plus-maze 
(EPM) as well as sensory hypersensitivity in the Von-Frey filament test, as well as increased pain 
scores in the formalin test (Rivat et al., 2010). Elevated pain scores following social defeat were 
reduced to control levels by chlordiazepoxide (GABAA agonist) as well as systemic administration 
of a CCK (cholecystokinin) antagonist (Rivat et al., 2010). Exposure to the EPM has been shown 
to be a stressor itself, and following exposure rats exhibited decreased paw withdrawal latencies 
in the hotplate test, which was reversed by a muscimol injection into the RVM (Cornelio, Nunes-
de-Souza, & Morgan, 2012).  
 Chronic stress has been shown to increase dendritic branching and spine density in the 
basolateral amygdala (Mitra, Jadhav, McEwen, Vyas, & Chattarji, 2005) and to increase 
spontaneous firing of BLA neurons (Rosenkranz, Venheim, & Padival, 2010). The BLA projects 
directly to the CeA through glutamatergic projections and indirectly through GABAergic 
interneurons located in the intercalated cell masses (ITC) (Ren & Neugebauer, 2010). In an 
arthritic model of pain, excitatory input from the BLA to the CeA increased, whereas inhibitory 
input decreased (Ren & Neugebauer, 2010). Additionally, reciprocal connections were 
strengthened between the CeA and the parabrachial nucleus (Neugebauer, Galhardo, Maione, & 
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Mackey, 2009). This pain related input from the BLA with nociceptive specific input from the 
spinal cord (Neugebauer et al., 2009).  
Chronic stress also affects the inhibitory regulation of the medial prefrontal cortex (mPFC) 
to the BLA. The mPFC and BLA have reciprocal projections that are important for emotional 
regulation as well as the generation of defensive responding (Quirk and Beer, 2006). In contrast to 
the amygdala, dendritic branches in the mPFC are reduced following chronic stress (Cook and 
Wellman, 2004). This reduction in the mPFC allows the amygdala to be more responsive to 
stressors. Indeed, lesion of the mPFC increased neuronal firing rate in the amygdala in response to 
acute cold stress (Correll, Rosenkranz, and Grace, 2005). Additionally, electrolytic lesion of the 
mPFC increased recovery of an extinguished fear (Quirk and Russo, 2000). Together, Decreased 
regulation by the mPFC and increased amygdala responsiveness to stress suggest an important 
contribution of the BLA to increased defensive responding leading to environmental 
hypervigilance that may contribute to the development of hyperalgesia. 
1.5 Hypotheses 
 In the current study bicuculline methiodide (a GABAA antagonist) was used to mimic the 
effects on the brain during exposure to a stressful stimulus. As stress hormones act within the BLA 
to reduce GABAergic signaling (Anderjaska, 2007), disinhibition of the BLA will allow for a 
similar effect within the brain without the need for a behavioral stressor. Bicuculline acts as a 
competitive antagonist of GABAA receptors by reducing chloride ion channel open times and 
opening frequency reducing GABAs normal induction of Inhibitory Post-Synaptic Potentials 
(IPSPs) (Johnston, 2013). Behaviorally, microinjection of bicuculline into the BLA of rodents 
resulted in an increase in heart rate and blood pressure (Sanders, 1991) similar to that observed 
follow stressor exposure. Peak behavioral effects were reached within 11.5 minutes and lasted for 
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23 minutes (Sanders, 1991). Microinjection of 20pmol of bicuculline into the BLA resulted in 
decreased social interaction, indicative of anxiety-like behavior (Shekhar, 1995). Additionally, 
.1µg of bicuculline in the BLA decreased time spent in the open arms of the elevated plus-maze 
as well as the number of open arm entries with no effect on total number of arm entries suggesting 
an anxiogenic effect (Zarrindast, 2008). Together these findings suggest that microinjection of 
bicuculline methiodide into the BLA is a good model to examine the effects of stress on pain 
sensitivity. However it is important to note that this only mimics one aspect of the stress response 
in one brain region. Chronic stress can have a multitude of effects in multiple brain areas as well 
as the body. Figure 13 illustrates other ways in which stress may affect the brain and can influence 
amygdalar activity through indirect routes as well. 
 The hypotheses for this study were as follows: First, immediately following bicuculline 
administration to the BLA, I expected that pain responsiveness would decrease as measured by 
amplitudes of VADs and VDSs.  This acute effect of bicuculline is hypothesized to mimic exposure 
to stressor (i.e., high predatory imminence - fear) and engage endogenous antinociceptive 
mechanisms. Likewise, as exposure to a predator can inhibit withdrawal reflexes, I expected a 
decrease in Spinal Motor Reflex (SMR) immediately after intracerebral injection of bicuculline. I 
expected to see an increase in VADs and VDS, with no change in SMRs, in the days and weeks 
following bicuculline administration.  This delayed hyperalgesia is hypothesized to reflect the 
aftereffects of stressor exposure (i.e., lower predatory imminence – anxiety) that produces 
environmental hypervigilance and reactivity to potential threats including noxious stimuli (i.e., 
hyperalgesia). I also expected that pain responsiveness in animals treated with saline injection 
would remain stable over time with no significant differences. Similarly, administration of 
bicuculline into brain sites surrounding the BLA should have also resulted in stable pain 
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responsiveness over time. Finally, I hypothesized that bicuculline would have no effect on the 
animals’ ability to vocalize and that changes in vocalizations were due to changes in pain 
sensitivity rather than an increase or decrease in ability to vocalize. 
CHAPTER 2 METHOD 
2.1 Subjects 
 Subjects were adult Male Long-Evans rats (between 226-250g upon arrival) (Charles 
River, Wilmington, MA). All subjects were housed in pairs in polycarbonate cages in a climate-
controlled vivarium and were given access to food and water ad libitum. The vivarium was on a 
12:12 light-dark cycle with lights on at 0700 hours. All procedures were conducted between 0800 
and 1800 hours. Upon arrival, rats were given one week to acclimate and then handled once per 
day for 1 week to minimize the possibility of stress due to human contact. 
2.2 Cannulation Surgeries 
The Institutional Animal Care and Use Committee of Wayne State University approved all 
procedures and surgeries were performed under aseptic conditions. Rats were anesthetized with 
isoflurane (induced at 5% and maintained between 2 and 3% throughout the procedure. Prior to 
incision, a local analgesic injection of lidocaine (.05 mg/kg) and bupivacaine (1.5 mg/kg) was 
applied locally. Additionally, an IP injection of meloxicam (1mg/kg) was given prior to the start 
of surgery.  Rats were implanted bilaterally with 26 gauge stainless steel guide cannulae (Plastics 
One, Roanoke, VA) above the BLA (2.8mm posterior to Bregma, 4.9 mm lateral from midline, 
and 6.4mm ventral from the top of the skull) using a stereotaxic apparatus. Coordinates were 
determined according to the rat brain atlas of Paxinos and Watson (Paxinos and Watson 1998). 
Guide cannulae were attached to the skull with 3 stainless steel bone screws (3/16”) and dental 
cement. Rats were allowed 7 days to recover before initiation of behavioral testing.  
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2.3 Testing Apparatus 
 Rats were placed in custom made Velcro suits and restrained to a Plexiglas pedestal to 
restrict movement during injections and behavioral testing. Testing was conducted in a lit, sound-
attenuating chamber with a ventilation fan. A window located on the door of the chamber allows 
for the monitoring of animals during testing. Tailshock was delivered through electrodes (0-guage 
stainless steel insect pins) in 20ms pulses at 25Hz for 1,000ms. Electrodes were placed 
intracutaneously on opposite sides of the tail. Spinal Motor Reflexes (SMR) were measured with 
a semi-isotonic displacement transducer (Lafayette Instruments Model 76614, Lafayette, IN) 
attached to the rat's tail with cotton thread. SMR was defined as movement of the transducer arm 
by at least 1.0mm following shock onset. Latency (ms), amplitude (mm), and magnitude (cm x 
ms) of tail movement were measured for each trial. Vocalizations were recorded by an 
omnidirectional boundary microphone (Optimus, Barcelona, Spain). The microphone was placed 
on the wall of the testing chamber approximately 15cm from the rat's head. Peak intensity was 
recorded in decibels as well as latency (ms) and duration (ms) of vocalizations during the shock 
presentations (VDS) and for 2,000ms following shock termination referred to as vocalizations after 
discharge (VADs). 
2.4 Pain Testing 
 Prior to the onset of testing rats were exposed to the Velcro suit and testing chamber for 20 
minutes per day for 2 days in order to reduce the effects of restraint stress. Testing began 
immediately following intracerebral injections. Baseline shock level was first determined based 
on vocalization and response rate. All animals began testing with a shock intensity of .4 milliamps. 
Vocalizations around 70 decibels or a 50% response rate maintained baseline at .4 milliamps. If 
vocalizations and response rate were higher, the shock intensity was reduced to .3ma. Decreased 
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vocalizations and response rates resulted in an increase in shock intensity to .5ma. Once 
established, this shock intensity was used throughout the remainder of the experiment. Trials 
consisted of 6 shocks and one catch-trial, in random order, to assess false alarm rates. There was 
a minimum inter-trial interval of 30 seconds, however the following shock was not given until 
vocalization and movement from the previous shock had ceased. The chamber was cleaned with 
5% ammonium hydroxide following each testing session in order to eliminate potential stress 
odors. Pain behaviors were assessed immediately following bicuculline administration (day 1) as 
well as 4,7,14, and 21 days following intracerebral injections (see figure 3). 
2.5 Drug Injections 
 Intracerebral injections were given through each cannula with a 33-gauge injector that 
extends 2.2mm beyond the end of the guide cannula. Bicuculline or saline was injected at a 
constant volume of .25μl delivered over one minute via an infusion pump (Harvard). Injectors 
remained in place for 2 minutes to allow the drug to diffuse into the tissue. A dose of 100 pmol of 
bicuculline was delivered in each hemisphere. 
2.6 Groups 
 Subjects were divided into 4 groups. All groups received an injection of saline prior to 
baseline pain testing. The following day began test day 1. An experimental group (n = 10) received 
an injection of bicuculline into the BLA on day 1 as described above. A drug control group (n = 
12) received another injection of saline on day 1. The anatomical control group (n = 6) had cannula 
surgically implanted as described above but in sites surrounding the BLA. All anatomical control 
animals received bicuculline on day 1. A vocal ability control group received cannula implantation 
to the BLA and followed all procedures as the experimental group, however during pain testing 
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they were exposed to 20 shocks of varying intensity ranging from .01 milliamps to 2.0 milliamps 
in order to elicit vocalizations despite bicuculline treatment .  
2.7 Histology 
 Following the last testing session rats were sacrificed by carbon dioxide asphyxiation and 
were then injected intracerebrally with .25μl of safrin-O dye in order to mark injection sites. Brains 
were then removed and placed in sugar buffered formalin for at least 24 hours. Brains were 
sectioned at 50μm on a freezing microtome. The site of injection was confirmed with the aid 
Paxino and Watson’s rat brain atlas (Paxino and Watson 1998). 
2.8 Data Analysis 
 Data were analyzed in two separate mixed factorial Analysis of Variance (ANOVA) in 
order to separately compare the analgesic and hyperalgesic components of the experiment. The 
first ANOVA compared baseline testing to test day 1 for SMR, VDS, and VAD measures. The 
second mixed factorial ANOVA compared baseline testing to days 4, 7, 14, and 21 for SMR, VDS, 
and VAD. Follow up analyses included separate repeated measures ANOVAs comparing saline or 
bicuculline over time. Additionally t-tests were run comparing saline to bicuculline at different 
test days of interest, as needed based on findings from the previous analyses. Sidak corrections 
were used to correct for multiple comparisons in the repeated measures ANOVAs and t-tests. One-
way repeated measures ANOVAs with Dunnett's post-hoc tests were used to analyze anatomical 
control subjects for SMR, VDS, and VAD measures comparing each test day to baseline 
responding. The same analysis was used for the vocal ability control group.  
CHAPTER 3 RESULTS 
3.1 Vocalizations 
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 Amplitudes for VADs and VDSs were analyzed using two mixed factorial ANOVAs. The 
first compared baseline to test day 1 for bicuculline and saline treated rats (see figures 4 and 5). 
There was a significant main effect of time for both VADs and VDSs (F(1, 130) = 12.85, p < .001 
and F(1, 130) = 49.17, p < .001 respectively). There was also a significant main effect of drug for 
VADs (F(1, 130) = 147.33, p < .001) and VDSs (F(1, 130) = 271.67, p < .001). The Time x Drug 
interaction was also significant (F(1, 130) = 27.08, p < .001 and F(1, 130) = 27.08, p < .001). To 
further understand the effects, separate paired samples t-tests were conducted for saline and 
bicuculline for VADs and VDSs. A paired samples t-test comparing bicuculline animals showed 
significant decrease in VAD and VDS amplitude on test day 1 compared to baseline (t(59) = 6.83, 
p < .001 and t(59) = 7.39, p < .001 respectively). There was no difference in saline animals on day 
1 compared to baseline for VADs (t(71) = 1.11, p = 0.27) or VDSs (t(71) = 1.58,  p = 0.12). VAD 
amplitudes for saline and bicuculline treated rats did not differ at baseline (t(130) = .761, p = .45) 
and there was a significant difference between saline and bicuculline on day 1 (t(130) = -7.25, p < 
.001). A similar effect was observed for VDS amplitudes. There was no difference between saline 
and bicuculline at baseline (t(130) = -.569, p = .570). There was, however, a significant difference 
on test day 1 (t(130) = -6.619, p < .001.  These findings demonstrate that immediately following 
bicuculline treatment the capacity of noxious tailshock to generate VADs and VDSs was reduced 
indicating an antinociceptive action of bicuculline injected into BLA.  Indeed, of the 10 rats tested 
only 1 produced VADs and 3 produced VDSs immediately following the injection of bicuculline 
into BLA.   
 The hyperalgesic component was measured using a mixed factorial ANOVA comparing 
baseline and test days 4, 7, 14, and 21 for both VADs and VDSs. There was a significant main 
effect of time (F(3.68, 520) = 8.65, p <.001 and F(3.63, 520) = 5.69, p <.001 respectively). A 
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significant main effect of drug was also observed for both VADs (F(1, 130) = 270.62, p < .001) 
and VDSs (F(1, 130) =  618.79, p < .001). The Time x Drug interaction for VADs was not 
significant (F(3.68, 520) = 1.68, p = .16) but was significant for VDSs (F(1, 130) = 27.08, p < 
.001). In order to further understand these effects separate one-way repeated measures ANOVAs 
were conducted. There was a significant main effect of bicuculline for both VADs and VDSs 
(F(3.423, 202.0) = 6.119, p < .001) and Dunnett’s post-hoc tests revealed that VAD amplitudes 
were elevated on days 4 and 14 while VDS amplitudes were elevated on days 7 and 14 compared 
to baseline. There was a significant main effect of saline on VADs (F(3.573, 253.7) = 6.352) but 
not for VDSs (F(3.659, 259.8) = 2.87). Dunnett’s post-hoc tests revealed that VAD amplitudes 
were significantly increased on day 14 and 21. VAD amplitude in bicuculline treated rats was 
significantly greater than saline rats on day 4 (t(130) = 2.52, p < .013) while no difference was 
observed on days 14 (t(130) = .926, p = .356) or 21(t(130) = .052, p = .958). VDSs were 
significantly greater in bicuculline rats compared to saline on day 7 (t(130) = 3.31, p = .001) but 
not on day 14 (t(130) = .597, p = .55). Locations of bicuculline and saline injections are shown in 
figure 6 as well as a photomicrograph of an injection site (figure 7). These findings suggest that 
VAD amplitudes are enhanced 4 days and VDS amplitudes are enhanced 7 days following 
bicuculline administration into the BLA, indicating a hyperalgesic effect. 
3.2 Spinal Motor Reflex 
A mixed factorial ANOVA compared baseline testing to day 1 for bicuculline and saline rats (see 
figure 8). In contrast to findings on vocalization amplitudes, there was no significant main effect 
of time (F(1, 130) = .075, p = .78) but there was a significant effect of drug (F(1, 130) = 1099.17, 
p < .001). No significant Time x Drug interaction (F(1, 130) = 3.28, p = .07) was observed.  The 
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reduction in vocalization amplitudes observed immediately following bicuculline treatment was 
not observed for SMR amplitude. 
 Baseline SMR amplitude was compared to testing days 4, 7, 14 and 21 for bicuculline and saline 
treated animals (see figure 8). There was no significant main effect of time (F(3.506, 520) = 1.26, 
p = .29). A main effect of drug (F(1, 130) = 2211.11, p < .001). There was a significant Day x 
Drug interaction (F(3.506, 520) = 3.94, p < .01). Within subjects contrasts were used to compare 
days 4, 7, 14, and 21 to baseline separately for saline and bicuculline rats. Bicuculline had no effect 
on SMR amplitude over time, (F(3.21, 236) = 1.70, p = .15). There was a significant effect of 
saline over time, (F(3.65, 284) = 4.09, p < .01). Dunnett’s post hoc tests showed that SMR 
amplitude decreased in saline rats on days 4, 7, and 14 compared to baseline responding.  
3.3 Anatomical Controls 
One-way repeated measures ANOVA of VAD (see figure 9a) and VDS (see figure 9b) 
amplitudes revealed significant changes across days of testing (VAD, F(5, 175) = 10.79, p < .001; 
VDS, F(5,175) = 4.72, p < .01).  Dunnett’s post-hoc analysis comparing baseline amplitudes with 
amplitudes on each test day showed that VAD amplitudes were elevated on days 7, 14, and 21 and 
VDS amplitudes were elevated on day 14. A one-way repeated measures ANOVA revealed no 
significant effect of bicuculline on SMR (see figure 9c) responding over time (F(5, 175) = 2.42,  p 
= .07). These findings suggest that the analgesic effect observed following bicuculline 
administration is specific to the BLA and not due to spread of the drug to surrounding brain areas. 
Injection sites and a photomicrograph of an injection site can be seen in figure 10. 
3.4 Vocal Ability Controls 
  In order to confirm that decreases in vocalizations were not due to bicuculline causing an 
inability to vocalize, a separate group of rats were exposed to varying shock levels from .01mA to 
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1.5mA. Vocalizations within the .3mA to .5mA range were analyzed in order to maintain 
comparisons with other experimental groups. A paired samples t-test revealed no significant 
difference in VAD, VDS, or SMR on day 1 compared to baseline responding. Similarly, a one-
way repeated measures ANOVA revealed no significant differences in responding on day 4, 7, or 
14 compared to baseline for VAD (F(4, 56) = 1.35, p = .26) VDS (F(4, 56) = .93, p = .45), or SMR 
(F(4, 56) = .811) see figures 11a, b, and c respectively. Additionally, response thresholds, or the 
minimum shock intensity necessary to elicit a response, were measured. A one-way repeated 
measures ANOVA revealed no significant main effect of bicuculline administration on VAD 
threshold over time, F(4,16) = 3.06, p = .094. Similarly a one-way repeated measures ANOVA 
showed no significant effect of bicuculline administration on VDS threshold over time (F(4,16) = 
4.18, p = .08). There was no main effect of bicuculline administration on SMR threshold over time 
(F(4,16) = 2.11, p = .18). These findings suggest that analgesic effects observed on vocalization 
measures was not due to an inability to vocalize following bicuculline injection into the BLA. 
Injection sites for vocal control rats can be seen in figure 12. 
CHAPTER 4 DISCUSSION 
The primary purpose of the present study was to evaluate how a key component of the 
defense circuit, the basolateral amygdala, contributes to the bimodal influence of stressors on pain 
responsiveness. In this study, intracerebral injections of bicuculline in the BLA were used to 
simulate the effects of stress on this region and pain responsiveness was assessed at various time 
points.  I demonstrated a bimodal response to bicuculline as pain responding decreased 
immediately following injection yet increased in the days and weeks following injection. To my 
knowledge, this is the first study to exhibit both stress-induced analgesia and stress-induced 
hyperalgesia in the same animals over time. Additionally this is the first study to show that 
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bicuculline injection into the BLA results in analgesia. The findings of this study could have 
profound effects on establishing a baseline from which to study the transition of the facilitating 
effects of stress (analgesia) to the debilitating effects of stress (hyperalgesia) on pain 
responsiveness.  
4.1 Stress-induced analgesia 
  Under normal circumstances the BLA is responsible for attaching emotional salience to 
environmental stimuli (Ledoux, 2000). Chronic stressors were shown to facilitate sensory 
transmission within the BLA through disinhibition of the GABAergic tone. Indeed chronic 
exposure to urocortin, a CRF 1 and 2 agonist, resulted in a decrease in spontaneous and stimulated 
IPSPs within the BLA, and an increase in the excitability of BLA projection neurons to afferent 
stimulation. Similarly this effect was seen following bicuculline administration as well (Rannie et 
al., 2004). Behavioral changes were also observed as urocortin injected in BLA resulted in 
increased heart rate and respiration rate and also resulted in decreased open arm exploration in the 
EPM – a behavioral measure of anxiety in rats (Rannie et al., 2004). Again, similar changes were 
observed following bicuculline injection into BLA, suggesting it is a good model to mimic the 
effects of stress.  
The analgesic effects of bicuculline injection into the BLA observed in the current study 
were strong and had anatomical specificity. Immediately following injection of bicuculline into 
the BLA pain responding decreased as measured by a decrease in the amplitude of both VDS and 
VAD. On the other hand, the amplitude of SMR was not influence by the intra-BLA administration 
of bicuculline.  As VAD and VDS are respectively organized at forebrain and medullary levels of 
the neuraxis, and SMR within the spinal cord these findings indicate that bicuculline injected into 
BLA preferentially suppresses pain transmission at supraspinal levels of the neuraxis.  The failure 
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of bicuculline to suppress SMR amplitude does not reflect the insensitivity of this response to 
antinociceptive treatments.  In previous studies, administration of morphine into the rostral 
ventromedial medulla or vPAG produced significant suppression of VAD, VDS, and SMR 
(Blanchard, Rodgers, Hendrie, & Hori, 1988; Borszcz, 2002), and the intrathecal administration 
of morphine, 5-HT, or norepinephrine was equally effective in suppressing VAD, VDS, and SMR 
(Borszcz, Johnson, Anderson, & Young, 1992). Similar to the present results, administration of 5-
HT, a 5-HT agonist or morphine into either the amygdala or thalamus produced selective 
suppression of VAD and VDS (Floyd, Price, Ferry, Keay, & Bandler, 2000; Gracely, McGrath, & 
Dubner, 1978; Maren, 2001; Mark, Ervin, & Yakovlev, 1963).  Therefore, the capacity of suppress 
SMR appears to be dependent on the site at which antinociceptive treatments are administered. 
Several studies reported suppression of the spinally organized tail flick response to radiant 
heat in rats following administration of morphine into BLA.  Helmstetter and colleagues reported 
that administration of morphine or µ-opiate agonists into BLA of pentobarbital-anesthetized rats 
produced suppression in tail-flick, and that this effect was expressed through the vPAG and RVM 
(Helmstetter, Bellgowan, & Poore, 1995; Helmstetter, Bellgowan, & Tershner, 1993; Helmstter, 
Tershner, Poore, & Bellgowan, 1998).  McGaraughty and Heinricher (2002) also reported 
suppression of tail flick in barbiturate-anesthetized rats following the injection of morphine into 
the BLA.  However, barbiturate anesthesia reportedly modifies the antinociceptive action of 
intracerebrally administered opiates in the tail-flick test (Ossipov & Gebhart, 1984; Smith, 
Robertson, & Monroe, 1992).  Whether barbiturate anesthesia modifies the antinociceptive action 
of opiates administered into the amygdala has not been directly tested.   
However, Nandiagama and Borszcz (2003) reported that injection of morphine into the 
BLA in conscious rats suppressed VAD and VDS but not SMR – findings similar to those found 
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in the present study.  This finding is consistent with other reports that microinjection of morphine, 
µ-opiates, enkephalinase inhibitors, or acetylcholine agonists into various forebrain sites including 
the amygdala and medial thalamus failed to alter withdrawal reflexes but suppressed supraspinally 
organized pain behaviors in conscious rats (Al-Rodhan, Chipkin, & Yaksh, 1990; Carr & Bak, 
1988; Dupouy & Zajac, 1997; Harte, Lagman, & Borszcz, 2000; Rodgers, 1978; Yeung, Yaksh, 
& Rudy, 1978).  Furthermore, administration of methysergide (serotonin receptor antagonist) into 
the amygdala failed to alter increases in SMR threshold produced by microinjection of morphine 
into vPAG, but reduced increases in VAD and VDS thresholds (Borszcz, 1999; Borszcz & 
Streltsov, 2000).  Similarly, inactivation of the amygdala, via microinjection of lidocaine, did not 
alter the suppression of tail-flick generated by electrical stimulation of vPAG (Oliviera & Prado, 
2001).  On balance, the available data indicates that these forebrain sites do not to contribute 
directly to suppression of withdrawal reflexes, or are only marginally involved in this suppression.   
The suppression of VDS and VAD amplitude immediately following bicuculline injection 
into BLA may reflect engagement of endogenous antinociceptive systems that occur during 
execution of circa-strike behaviors (responses that occur immediately before, during and 
immediately after confrontation with a predator) when predatory imminence is high.  For the rat 
these behaviors include biting, jumping, vocalizations, and attempts to escape.  Engagement of 
endogenous antinociceptive systems during these times enables the individual to continue 
executing defensive behaviors in the face of painful injury (Bolles, 1980; Fanselow & Lester, 
1988; Perusini and Fanselow, 2016).   For example, analgesia has been reported when rats are 
exposed to a cat (Lictman and Fanselow, 1990; Lester & Fanselow, 1985) and following 
conditioned fear (Fanselow, 1986; Fanselow & Helmstetter 1988; Rea, Lang, & Finn, 2009; Rea, 
Roche, & Finn, 2011).  Odors from stressed rats also resulted in opiate analgesia in unstressed rats 
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(Fanselow, 1985; Fanselow & Sigmundi, 1986). I propose that the injection of bicuculline into 
BLA and subsequent placement in the testing chamber could pose an imminent threat and therefore 
activate circa-strike behaviors including activation of the endogenous analgesic system.  
Consistent with this suggestion are reports that administration of bicuculline into BLA produces 
behavioral and autonomic responses that mimic threat exposure (Sanders, 1991; Shekhar 1995). 
The findings presented here also highlight a possible mechanism for the analgesic effect produced 
by fear. As the amygdala provides excitatory inputs into the defense circuit, a reduction in 
GABAergic signaling is a likely candidate for the effects of fear and stress on pain responsiveness 
(Shaikh, Schubert, & Siegel, 1994).  Consistent with this notion is the recent finding that 
muscimol, a GABAA agonist administered into the BLA, had the opposite effect and blocked the 
expression of fear-induced analgesia (Rea, Roche, & Finn, 2011). Together, these findings suggest 
an important role of the GABAergic system in regulating amygdala output to the defense circuit 
during times of fear and subsequently expression of stress-induced analgesia. 
Although audible vocalizations are part of the circa-strike behavioral repertoire that are 
designed to disorient the predator and facilitate escape, pain-induced vocalizations during these 
times may be suppressed.  As pain-induced vocalizations (especially VAD) are a validated 
measure of rats’ emotional response to pain it would be beneficial for successful escape that 
emotional responses to pain are suppressed to the circa-strike epoch.  That is, brain processing of 
pain (as reflected in pain-induce vocalizations) would be suppressed during this time so as not to 
interfere with the brain’s organization of innate behavioral patterns designed to enable the rat to 
cope with a highly imminent predator.  This interpretation suggests that are multiple inputs to the 
defensive aggression circuit and that during imminent threat by a predator those sensory inputs 
that represent the predator activate the defense circuit and generate behaviors (including 
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vocalizations) that enable the rat respond to that threat.  At the same time, pain inputs to the defense 
circuit are suppressed; thereby, preventing pain inflicted by the predator to redirect behavior 
toward the injury.  This selective suppression of pain inputs to the defense circuit represents an 
antinociceptive action rather than a general suppression of defensive responding.  This 
interpretation can account for my observation that whereas injection of bicuculline into BLA 
nearly eliminated pain-induced vocalizations, rats vocalized when being placed into or being 
removed from the testing chamber.  Presumably the experimenter (who is temporally associated 
with BLA injections) comes to represent a predator and evokes vocalizations while handling the 
rat, but pain-elicited vocalizations are suppressed. 
While emotional responding to pain during the execution of circa-strike behaviors are 
suppressed it may still be beneficial for pain-elicited spinally organized withdrawal reflexes to 
remain intact.  During confrontation with the predator the rat’s ability to reflexively withdrawal a 
limb that in under attack may minimize damage to that limb so preserve the capacity to engage in 
escape behaviors.  This interpretation could account for our finding that whereas emotional 
responding to pain (vocalizations) is suppressed following bicuculline treatment spinal withdrawal 
reflexes (SMR) remain intact. 
A potential mechanism to explain the analgesia produced by bicuculline administration 
into BLA could lie in projections from the BLA to the vlPAG.  The vlPAG is a nodal structure of 
the endogenous analgesia system (Borszcz, 1999; Basbaum & Fields, 1984).  Previous work from 
this laboratory demonstrated that injection of morphine into vlPAG produces preferential 
suppression of VAD and VDS, which is mediated by its reciprocal connections with intralaminar 
thalamic nuclei and the amygdala (Borszcz, 1999; Borszcz & Strelstov, 2000; Munn et al., 2009).  
Although the BLA sends neuronal projections to the vlPAG, it appears that the primary input from 
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the BLA to vlPAG includes a synapse within the central amygdaloid nucleus (CeA).  Earlier 
studies reported that the antinociceptive action of opiates injected into BLA were blocked by 
inactivation of the vlPAG, but the impact of CeA inactivation to this antinociceptive action has 
not been evaluated. I hypothesize that following bicuculline administration to the BLA, reduced 
GABA signaling increases excitatory glutamatergic projections to the CeA, which then activates 
antinociceptive projection neurons in the vlPAG.  This activation results in μ-opioid mediated 
analgesia (da Costa Gomez, 1995).  Indeed, bilateral injection of NMDA into the CeA resulted in 
antinociception as measured by a selective increase in VAD and VDS thresholds (Spuz and 
Borszcz, 2014). Likewise, NMDA injection to the CeA increased c-Fos in the vlPAG, and 
microinjection of a μ-opioid receptor antagonist in vlPAG blocked the increases in VAD and VDS 
thresholds that followed NMDA injection into CeA (Spuz and Borszcz, 2014).   
Exposure to environmental threats also elicits a stress response that includes activation of 
the HPA-axis.  The hypothalamus releases CRF into the portal system of the anterior pituitary 
causing the release of ACTH into the bloodstream.  ACTH acts on the adrenal cortex and adrenal 
medulla to release glucocorticoids and catecholamines, respectively.  These stress hormones 
provide feedback (directly and indirectly) to the brain circuits that control sensitivity and reactivity 
to threatening stimuli.  It is well established that the BLA is the principal site within the defense 
circuit where stress hormones act to enhance responding to threatening stimuli (Fig. 5).  
Epinephrine, which does not cross the blood–brain barrier, induces the release of norepinephrine 
(NE) in the BLA by activating vagal afferents to the nucleus of the solitary tract (NTS). 
Noradrenergic neurons in the NTS project directly to the BLA, and indirectly via the locus 
coeruleus (LC).  Glucocorticoids (GCs) freely enter the brain and bind to glucocorticoid receptors 
in brainstem noradrenergic neurons to potentiate norepinephrine release in the BLA, as well as 
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postsynaptically on BLA neurons.  NE and GCs bind to GABAergic interneurons in BLA to 
decrease GABAA receptor-mediated inhibition of BLA projection neurons (Duvarci & Pare 2007, 
Rodriguez Manzanares et al. 2005, Tully et al. 2007), thereby allowing for increased excitability 
of BLA projection neurons to sensory inputs.  With high levels of predatory imminence, I 
hypothesize that BLA outputs to the dmVMH and dlPAG are enhanced so to promote execution 
of circa-strike behaviors and at the same time outputs to CeA are engaged that activate endogenous 
antinociceptive systems that reduce emotional responding to injury during confrontation with the 
threat. 
4.2 Stress-induced hyperalgesia 
 The hyperalgesic effect observed in the current study were not as strong as the analgesic 
effect and had limited anatomical specificity. In the days following bicuculline administration the 
analgesic effects wore off and an increase in pain responsiveness was observed. Vocalizations 
During Shock were elevated 7 and 14 days following injection. No effects of saline injection on 
VDS over time was observed. Similarly VADs were elevated in bicuculline treated animals were 
elevated at 4 and 14 days following injection.  
 Stress-induced hyperalgesia is not as well studied as analgesia, despite its role in human 
chronic pain conditions. As mentioned previously, this could be due to an inability to distinguish 
clearly between fear and anxiety in animal models (Rhudy and Meager, 1999). As fear suppresses 
pain leading to an analgesic effect, anxiety increases environmental scanning and sensory 
receptivity, thus leading to a hyperalgesic effect (Rhudy and Meager, 2000). The differences in 
pain responding during fear and anxiety could be the driving force behind the bimodal responses 
observed in the current study. 
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 Upon initial injection of bicuculline and subsequent pain testing there is an analgesic effect. 
This is likely because the time of injection aided by exposure to the experimenter and placement 
into the testing chamber could be considered a present stressor and thus results in a fear response. 
In the days following, however, anticipation of further injections and pain testing could result in 
anxiety.  A symptom of PTSD and other anxiety disorders is hypervigilance, which is reflected in 
the preoccupation with possible unknown threats, constantly watching and scanning surroundings 
coupled with a persistent sense of insecurity. Somatic hypervigilance produces over-interpretation 
of the threat posed to the individual by a noxious stimulus or injury; thereby, augmenting their 
emotional response to pain (Asmundson & Katz 2008; Defrin et al., 2008; Sharp & Harvey, 2001). 
The increases in the amplitude of VAD and VDS that developed in the present study may reflect 
development of somatic hyperalgesia.   Again, this idea is consistent with Fanselow's predator 
imminence theory. Bicuculline administration may result in the development of an anxiety state 
and therefore result in pre- and post- encounter behaviors such as hypervigilance.  
 Interestingly, VADs were elevated 14 and 21 days following saline injection to the BLA. 
This increase in vocalizations could be due anxiety produced following repeated testing. It is 
important to note, however, that there were no measures of anxiety (i.e., elevated plus maze) taken 
over the course of this study.  
 The findings here are in line with other studies examining stress and hyperalgesia. 
Repeated social defeat stress in rodents resulted in increases in anxiety-like behavior as well as 
increased pain sensitivity (Rivat et al., 2010). Stress hormones act within the amygdala to decrease 
GABAergic signaling (Anderjaska, 2007), therefore it is not surprising that in the days following 
bicuculline injection there is an increase in pain responding. This also helps to explain the increase 
in VADs noted following saline injection. This finding is supported by the finding that stress 
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induced increases in pain scores were reduced with systemic treatment by the benzodiazepine, 
chlordiazepoxide which is a GABAA agonist (Rivat et al., 2010). 
 The reduction in GABAergic tone in the BLA following repeated stressors, or in this case 
through injection of bicuculline, allows increased activity within BLA projection neurons. As the 
amygdala provides emotional meaning to sensory inputs (Ledoux, 2000), increased BLA activity 
through decreased IPSPs (Rannie, 2004) as well as reduced after-hyperpolarizations (Atchley, 
2012) could provide an opportunity for increased responding to emotionally significant stimuli as 
well as responding to stimuli that were not previously significant (i.e. an anxiety disorder 
develops). For example, LTP develops within the amygdala following chronic immobilization 
stress (Suvrathan, 2015). After 10 days of immobilization stress there was an increase in EPSP 
slope, an increase in the NMDAR to AMPAR ratio, and a general increase in NMDAR (Suvrathan, 
2015). Furthermore, there was also an increased number of silent synapses, those that contain 
NMDARs but no AMPARs (Suvrathan, 2015).  These synapses will increase the magnitude of 
LTP and may provide a mechanism for the difference in normal fear compared to pathological 
fear. Based on this evidence, chronic stress can lead to plasticity within the amygdala allowing it 
to become hypersensitive to environmental stimuli thus generating affective disorders (Suvrathan, 
2015).  Because of the increase in excitation and a reduction in GABAergic inhibition, BLA 
projection neurons send excitatory projections to the dmVMH and mPFC (Porrino, Crane, & 
Goldman-Rakic, 1981) which then send excitatory projections to the dlPAG (Keay and Bandler, 
2001) which in turn increases defensive responding such as an increase in vocalizations (see figure 
13). 
 Within the context of the present model, I propose that sustained activation of the HPA-
axis that follows exposure to a fear-inducing stimulus (i.e., predator) leads to long-lasting down-
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regulation of GABAergic inhibition of BLA project neurons (see figure 13).  This down-regulation 
leads to enhanced excitability of BLA projection neurons to glutamatergic sensory afferents.  
Electrophysiological studies indicated that previous stress and repeated administration of 
corticotrophin-releasing factor receptor agonist into the BLA reduces GABAergic 
neurotransmission in this structure, increases the response of BLA projection neurons to sensory 
stimulation (Rodrıguez Manzanares et al, 2005; Rainnie et al, 2004).   This enhanced excitability 
promotes NMDA-mediated synaptic plasticity within the BLA resulting in long-term heightened 
sensitivity of BLA projection neurons to sensory inputs.  The augmented output of glutamatergic 
BLA projection neurons to the defense circuit (i.e., dlPAG and dmVMH) also promotes NMDA-
mediated synaptic plasticity within these sites.  As a result, augmented defense responses are 
elicited to threatening stimuli and non-threatening stimuli are capable of eliciting defense 
responses (i.e., an anxiety disorder develops).  As the dlPAG and dmVMH receive nociceptive 
afferents the BLA/stress-mediated neuroplasticity within these sites likely underlies long-term 
increases in pain sensitivity that accompanies anxiety disorders.  
 I hypothesize that a lower level of arousal is associated with anxiety compared to that 
associated with fear produced by direct confrontation with a threat. For example, Rainnie and 
colleagues (2004) found that repeated administration of a low dose of urocortin, a CRF 1 and 2 
agonist, increased BLA excitability at doses that had no acute effects on anxiety-like behavior.     
The reduced arousal with anxiety may reflect a muted but steady state activation BLA projection 
neurons which may be sufficient to activate the defense circuit but not sufficient to activate the 
putative projections from CeA to the vlPAG.  As a result, anxiety produces a steady state somatic 
hypervigilance through activation of the defense circuit that facilitates pain processing within the 
defense circuit; thereby, producing persistent augmented responding to painful stimuli.  Because 
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the BLA outputs to CeA are not engaged during anxiety the hypersensitivity of the defense circuit 
to pain input is not opposed by activation of the endogenous analgesia circuit and hyperalgesia 
results (Fig 13).  Alternately, the CeA neurons in CeA that receive inputs from BLA projection 
neurons may have a higher threshold of activation than those in the defense circuit.  The figure 
shows that as stress hormones act within the BLA to reduce the tonic GABAergic inhibition, the 
BLA becomes more susceptible to the glutamatergic sensory input resulting in BLA projections to 
the dlPAG and dmVMH that results in the expression of defensive responses and hyperalgesia in 
response to the anxiety-inducing stimuli (i.e. anxiety-induced hyperalgesia). 
 Reciprocal projections between the BLA and mPFC can also explain the generation of 
hyperalgesia following stress exposure. Bidirectional connections between the BLA and mPFC 
are important for fear conditioning and extinction (Marek, 2013, see Fig 2). In humans, fMRI 
studies show that fear-inducing stimuli activate the amygdala (Morris, 1996) and the PFC is 
activated during fear extinction (LaBar, 1998). Additionally, Mobbs et al., 2010 showed shifting 
activation between the PFC and amygdala based on threat distance. When a tarantula was placed 
close to a participant’s foot via real-time camera feed in an fMRI scanner, there was greater 
activation in the amygdala compared to greater activation in the PFC from a more distant tarantula. 
Similarly, stimulation of BLA projections to the mPFC using optogenetic approaches produced 
anxiety-like behavior in the EPM and reduced social behavior while inhibition produced anxiolytic 
effects (Tye, 2016).  
Inhibitory control of the mPFC over the BLA is decreased following stress as evidenced 
by decreased dendritic branching (Cook and Wellman, 2004) and an increase in amygdalar firing 
rate following mPFC lesion (Correll, Rosenkranz, and Grace, 2005). This decrease in inhibition 
allows for the activation of BLA projections to the mPFC that then facilitate anxiety responses 
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(Tye, 2016). Thus, the mPFC appears to have a dual role capable of producing anxiogenic effects 
as well as anxiolytic effects (Lisboa, 2010). While further work is needed to elucidate these 
differential effects there is evidence to suggest that these opposing responses are generated by the 
prelimbic cortex (PL) and the infralimbic cortex (IL). Inhibition of the PL resulted in an increase 
in heart rate following acute restraint stress, while inhibition of the IL resulted in a decrease in 
heart rate (Tavares, 2009). These findings suggest that the IL facilitates restraint-evoked responses 
while the PL reduces these responses (Tavares, 2009). These structures also differ in their cortical 
and subcortical projections (Vertes 2004). Of particular interest here is that there are dense 
projections from the IL to the dlPAG (Chiba, Kayahara, and Nakano, 2001).  
In context of the current experiment, I hypothesize that in the days following bicuculline 
injection, increased activity within the BLA amplifies activation of projections to the infralimbic 
cortex which then sends excitatory signals to the dlPAG generating defensive responding and thus 
contributing to the development of the hyperalgesic effect observed here.  
4.3 Anatomical Specificity 
 Administration of bicuculline into brain sites surrounding the BLA yielded similar results 
to that of saline injections within the BLA. There was an increase in VAD responding compared 
to baseline on day 7, 14, and 21. VDS responding was elevated on day 14 compared to baseline. 
There was no effect on SMR responding following injection to sites surrounding the BLA. These 
findings suggest that the hyperalgesic effects following injection of bicuculline into BLA is 
generated by its spread to sites outside the BLA.  Given the limited number of rats tested at each 
extra-BLA site it is not possible to conclude which site(s) outside the BLA may account for the 
hyperalgesia observed in the present study.  On the other hand, the spread of intracerebral 
bicuculline injections made in .25µl is estimated to be in the range of .145mm - .28mm (radius) 
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which is outside the range of the extra-BLA sites sampled in the present study.  Smith & Berridge 
(2005) mapped the effects of bicuculline microinjected into the ventral pallidum on eating and 
taste ‘hedonic’ reactions in rats.  They assessed the spread of their injections by measuring plumes 
of Fos-like protein immunoreactivity around the microinjection sites.  As stated by the authors the 
Fos plume reflects a local zone of functional modulation induced by the drug and provides 
quantitative information on intensity and size of the local activation zone.  The boundaries of the 
plume reveal where the drug has the most intense functional impact, even if drug molecules spread 
further beyond the plume in lower concentrations insufficient to trigger gene transcription.  Thus, 
a Fos plume provides objective information on the extent of tissue activation most likely to mediate 
functional effects of drug microinjections. Their Fos plume analysis revealed that .2 µg bicuculline 
injected in .5 µl produced an intense inner zone of activation with a radius of .29 mm and an outer 
zone of low activation with an additional .27 mm radius = total zone of activation of .56 mm 
(radius).  In the current study, the dose of bicuculline was 1/4 (100 pmol = .05 µg) and the injection 
volume was 1/2 (.25 µl) that used by Smith & Berridge.  A conservative estimate of the functional 
spread of bicuculline in the current study is .145 mm (inner zone) - .28 mm (total zone) (see figure 
14). 
 These findings strongly suggest that the analgesic effect observed during bicuculline 
administration to the BLA is specific to this brain area as there is no analgesic effect found when 
bicuculline is injected to sites surrounding the BLA. The current results suggest that amygdala 
activation is required for the analgesic effect observed here. 
 The findings from the anatomical specificity study also suggest that the hyperalgesic effect 
observed following saline injection into the BLA could be due to anxiety developed from the stress 
of repeated pain testing. It is possible that administration of bicuculline sped up or increased this 
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development of anxiety, as VADs were first elevated 4 days following injection compared to 7 
days in the anatomical specificity animals and 14 days for saline injected animals. A similar effect 
was seen in VDS responding with vocalizations first elevated in bicuculline-injected animals after 
7 days. The first elevated VDS responding wasn't seen in anatomical specificity animals until 14 
days after injection, and no elevation was observed in animals injected with saline into the BLA.   
4.4 Vocalization Controls 
 In order to verify that the analgesic effect observed wasn't an inability of the animals to 
vocalize due to bicuculline administration, shocks of varying intensity were given before, during, 
and in the days following injection. Injection of bicuculline into the BLA had no effect on VAD, 
VDS, or SMR threshold, or the minimum intensity stimulus necessary to elicit a response. Animals 
were able to vocalize at a variety of shock intensities, suggesting that bicuculline did not interrupt 
the vocal ability of the rats. Contrary to the earlier findings in this study, the vocalization control 
group did not exhibit an analgesic or hyperalgesic effect when vocalizations between .3 and .5mA 
only were measured. This failure to replicate the previously observed effects could be due to 
inherent differences within the rats, as these experiments were completed in months following 
completion of the other experimental and control groups. Furthermore, the stronger shock 
intensities may have decreased the analgesic effect of bicuculline administration as it may have 
been perceived as more stressful and therefore facilitated a hyperalgesic response. It is also 
important to note that the rats in the vocalization control group had a significantly higher baseline 
compared to the other experimental groups, suggesting they may have been more sensitive to the 
experimental procedures to begin with. This increase in baseline measures would also explain the 
lack of an observed increase in vocalization behaviors around day 14 that was seen in the 
experimental group, saline controls, and anatomical controls.  
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4.5 Future Directions 
 The findings presented in the current study create numerous routes for future research. 
First, it has been noted that while I am hypothesizing the hyperalgesic effect observed in the days 
following bicuculline administration is due to the development of anxiety, it is not directly 
measured in these experiments. I plan to add a measure of anxiety using the elevated plus-maze to 
confirm that these changes in pain responsiveness are consistent with the development of anxiety. 
In the current experiments, I have shown that disinhibition of the BLA leads to biphasic effects on 
pain responsiveness. Future research should focus effects of bicuculline administration on other 
brain areas, such as the CeA, dmVMH, and dlPAG as a function of time. It is important to establish 
the diverging mechanisms in which stress, and more specifically disinhibition of the BLA, 
contributes to the opposing pain responses observed here.  
4.6 Conclusions 
 The findings presented here support my hypotheses. I first hypothesized that bicuculline 
administration would immediately decrease pain responsiveness as measured by VADs and VDS. 
The results of this experiment confirmed this hypothesis. Increases in vocalizations observed in 
VADs and VDS on days 4 and 14 indicate long-term changes in pain sensitivity. As expected, no 
decrease was found immediately following saline injection in the BLA. In contradiction to my 
hypothesis, there was an increase in VADs on days 14 and 21 following saline treatment and no 
changes in VDS observed. Similarly to the saline treated animals, bicuculline administration to 
sites outside of the BLA did not result in a decrease in pain responsiveness immediately following 
injection. There was however, a significant increase in VADs and VDS on 7,14, and 21, and day 
14 respectively. Consistent with my hypothesis, bicuculline administration does not appear to 
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interrupt the animals' ability to vocalize, as bicuculline administration did not prevent responding 
at varying shock levels.  
 In conclusion, I have shown here that a single bicuculline injection into the BLA can have 
biphasic effects on pain responsiveness as a function of time. The findings here support stress-
induced analgesia as well as stress induced hyperalgesia. These findings seem to be specific to the 
BLA and are not due to changes in vocalization ability.  
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Figure 1. Columnar Organization of the PAG. This figure from Keay and Bandler (2001) describes 
the 3 columns of the PAG. The different columns play roles in different types of coping behaviors 
and lead to differences in defensive responding. 
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Figure 2. The subcortical defense circuit. This figure shows the connections between structures 
of the subcortical defense circuit and sites of nociceptive input to this circuit. 
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Figure 3. Experimental design timeline. All animals were given intracerebral injections of saline 
for baseline pain testing. The following day either saline or bicuculline was injected to the BLA 
or surrounding sites. Each rectangle represents a session of pain testing. 
  
38 
 
 
 
 
Figure 4. Vocalization after discharge. VAD amplitudes (mean ± SEM) were measured 
following tail shock over time. Bicuculline injection resulted in an immediate decrease in 
vocalization amplitude followed by an increase on subsequent test days. * = Bicuculline 
significantly different from baseline. @ = Saline significantly different from baseline. # = 
Bicuculline significantly different compared to saline. 
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Figure 5. Vocalization during shock. Amplitudes of VDSs (mean ± SEM<) were measured at 
different time points. Bicuculline injection resulted in an immediate decrease in amplitude 
followed by an increase on subsequent test days. * = Bicuculline significantly different from 
baseline. # = Bicuculline significantly different compared to saline. 
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Figure 6. Location of injection sites. The location of injection was determined with an injection 
of safranin-O dye following conclusion of the experiment.  Red circles represent bilateral 
bicuculline injections. Green triangles represent bilateral saline injections.  * mm from bregma 
(Paxinos and Watson, 1998). 
  
-2.64 mm* 
-2.76 mm* 
-2.92 mm* 
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A.                                                                        B. 
Figure 7. Injection site photomicrographs. An example of the confirmation of injection site 
following injection of safranin-O dye. Note the location of the tissue damage surrounded by pink 
tissue located within the teardrop shape of the BLA. (A) Saline injection. (B) Bicuculline 
injection. 
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Figure 8. Spinal Motor Reflex. The SMR amplitude (mean ± SEM) was measured by a 
displacement transducer attached to the rats tail by a cotton thread. Bicuculline injection had no 
effect on SMR. There was a decrease in SMRs in saline treated animals. @ = Saline responding 
significantly different compared to baseline. 
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A.                                                                         B. 
                          
                    C. 
Figure 9. Anatomical Specificity of analgesic and hyperalgesic effects. In order to verify 
that the effects of bicuculline injection on VADs, VDSs, and SMRs, bicuculline was 
injected to sites surrounding the BLA. There were no immediate effects of bicuculline 
injection on any measure (day 1), however elevated vocalizations were observed in days 
following injection. * = significantly different compared to baseline responding 
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Figure 10. Anatomical control injection locations. Injection sites are indicated by red ovals. 
Overlaid to the left of the plate is a photomicrograph of an actual injection location confirmed 
with safranin-O dye. 
45 
 
 
 
                              
A.           B. 
                                         
      C. 
Figure 11. Vocal ability controls. In order to verify that the analgesic effect observed during 
vocalization measures, varying shock intensities were delivered in order to elicit vocalizations 
from bicuculline treated animals for VADs (A) and VDSs (B). SMR response (C) was also 
analyzed. Data are represented as mean ± SEM. 
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Figure 12. Vocal ability control injection sites. Blue squares represent the location within the 
BLA in which a bilateral injection of bicuculline was delivered. 
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Figure 13. Proposed mechanism of analgesia and hyperalgesia. Diagram whereby stress hormones 
augment emotional responding to pain (see text for details).  Stress hormones induce synaptic 
plasticity in the basolateral amygdala (BLA) thereby augmenting its response to sensory input.  
Augmented output of BLA to the dorsomedial ventromedial hypothalamus (dmVMH) and 
dorsolateral periaqueductal gray (dlPAG) produced enhanced emotional reactivity to threatening 
stimuli, including noxious stimuli.  NTS = nucleus of the solitary tract, PGi = nucleus 
paragigantocellularis, LC = locus coeruleus, CRF = corticotropin-releasing factor, NE = 
norepinephrine, GABA ((gamma-aminobutyric acid), GLU = glutamate. CeA = central 
amygdaloid nucleus.  Adapted from de Quervain et al., 2009. 
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Figure 14. An estimation of functional spread of Bicuculline. Based on dose and total injection 
volume compared to calculations from Smith and Berridge (2005), a total functional radius of 
.28mm is estimated and shown here. Red circle indicates bicuculline injection within the BLA 
and yellow circles indicate bicuculline injections in this study outside of the BLA. 
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 Stress produces bimodal effects on pain peception. During exposure to a stressor pain 
responses are inibited (i.e. stress-induced analgesia). However, following long-term exposure to a 
stressor increases in responsiveness to painful stimuli may develop (i.e. stress-induced 
hyperalgesia). Here I evaluated how a key component of the subcortical defense circuit and target 
of stress hormones contributes to the development of both stress-induced analgesia and 
hyperalgesia. Bicuculline methiodide, a GABAA antagonist, injected into the basolateral amygdala 
was used to mimic the neural effects of a stressor or threat exposure. Immediately following 
injection pain responsiveness was decreased as measured by vocalizations after discharge and 
vocolizations during shock following a tailshock. In the days and weeks following bicuculline 
injection pain responsiveness became elevated compared to control rats. These findings suggest 
that pain responsiveness can be mediated by a reduction in GABAergic signalling within the 
basolateral amygdala following stress exposure. 
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